期刊文献+

Toll样受体4、环氧化酶-2和前列腺素受体EP2在溃疡性结肠炎结肠上皮中的表达 被引量:6

Expressions of TLR4 and COX-2,EP2 in colonic intestinal epithelium of ulcerative colitis
原文传递
导出
摘要 目的通过检测溃疡性结肠炎(UC)结肠上皮Toll样受体4(TLR4)、环氧化酶-2(COX-2)、前列腺素受体EP2的表达及相互关系的研究,为UC的临床治疗及癌变预防提供新的思路。方法选取33例活动期UC、11例缓解期UC及23例正常人作为对照进行前瞻性研究,进行免疫组化检测每例结肠上皮的TLR4、COX-2、EP2的表达。结果 TLR4、COX-2、EP2在活动期UC患者结肠上皮和炎症细胞中的染色积分分别是8.76±2.829、7.45±3.063、7.82±2.417,在缓解期UC组的染色积分分别是3.73±1.348、3.00±1.183、3.64±1.804,在正常对照组的染色积分分别是4.91±1.782、2.61±1.196、2.65±1.152,活动期UC患者结肠上皮和炎症细胞中的TLR4、COX-2、EP2的表达均高于UC缓解期及正常结肠黏膜(P<0.01),三者之间表达呈正相关;TLR4在活动期UC患者病理I级、Ⅱ级、Ⅲ级的染色积分分别是6.76±2.016、10.36±2.063、12.00±0.000,EP2在活动期UC组病理Ⅰ级、Ⅱ级、Ⅲ级的染色积分分别是6.71±2.519、8.73±1.794、9.60±1.342,活动期UC患者的TLR4、EP2的表达与病理分级呈正相关(P<0.01),COX-2在活动期UC组病理I级、Ⅱ级、Ⅲ级的染色积分分别是6.76±3.212、8.18±2.136、8.20±4.266,COX-2的表达与病理分级无明显相关(P>0.05)。结论 TLR4、COX-2、EP2在活动期UC患者中的表达显著上调,且三者之间呈正相关,提示TLR4及EP2可作为UC治疗及其相关性结直肠癌预防的新靶标。 Objective To provide the new thought to the treatment of ulcerative colitis and cancer chemoprevention by detecting the expressions of TLR4 and COX-2, EP2 in epithelium of UC and studing the relationships among them. Methods Thirty-three patients with active UC, eleven patients with remission of UC and twenty-three normal control subjects were recruited into this trial, the expressions of TLR4, COX-2 and EP2 in colonic tissues of the patients with active UC, remission of UC and normal subject controls were evaluated by immunohistochemistry. Results The dyeing integral of TLR4, COX-2, EP2 in colonic epithelium and in flammatory cells in the patients with active UC are respectively 8.76 ± 2. 829,7.45 ±3. 063,7.82 ±2. 417 ,and those in the remission of UC group are respectively 3.73 _± 1. 348,3.00_± 1. 183, 3.64 ± 1. 804 ,those in the normal control group are respectively 4.91 ± 1. 782,2.61 ± 1. 196,2.65 ± 1. 152. The expressions of TLR4, COX-2 and EP2 protein in colonic epithelium and in flammatory cells in the patients with active UC were higher than those in the patients with remission of UC and normal controls (P 〈 0.01 ). Also there was a direct positive correlation among the expressions of TLR4, COX-2 and EP2. The dyeing integral of TLR4 in activite UC patients pathologic grade Ⅰ, Ⅱ ,Ⅲare respectively 6.76 ± 2. 016,10.36 ± 2. 063,12.00 ± 0. 000, those of EP2 are respectively 6.71 ± 2.519,8.73 ± 1. 794,9.60 ± 1. 342. In the patients with active UC, the expressions of TLR4 and EP2 were closely related with pathological grade ( P 〈 0.01 ) ; However the dyeing integral of cox-2 in activite UC patients pathologic grade Ⅰ, Ⅱ ,Ⅲ are respectively 6.76 ± 3. 212,8. 18 ± 2. 136,8.20 ± 4. 266, the expression of COX-2 was no related to pathological grade( P 〉 0.05). Condusions The expressions of TLR4, COX-2 and EP2 were significantly upregulated in the intestinal epithelium of active UC; also there was a direct positive correlation among the expressions of TLR4, COX-2 and EP2
出处 《中华消化病与影像杂志(电子版)》 2013年第2期34-38,共5页 Chinese Journal of Digestion and Medical Imageology(Electronic Edition)
关键词 结肠炎 溃疡性 TOLL样受体4 环氧化酶2 受体 前列腺素 免疫组织化学 Colitis, Ulcerative Toll-like receptor 4 Cyclooxygenas 2 Receptors, Prostaglandin Immunohistochemistry
  • 相关文献

参考文献20

  • 1Liu ES, Ye YN, Shin VY, et al. Interaction of cigarette smoking with cyclooxygenase-2 on ulcerative colitis- associated neoplasia in mice. Cancer Invest, 2007, 25 (8) : 750-757. 被引量:1
  • 2Kotakadi VS, Jin Y, Hofseth AB, et al. Ginkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosis. Carcinogenesis, 2008,29(9) :1799-1806. 被引量:1
  • 3Chan AT, Ogino S, Fuchs CS. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med, 2007,356(2l) : 2131-2142. 被引量:1
  • 4Carlo E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 ( TLR3 ) and TLR4 in inflammatory bowel disease. Infect Immun, 2000, 68(12) : 7010-7017. 被引量:1
  • 5Fukata M, Chen A, Vamadevan AS, et al. Toll-like receptor-d (TLR4) promotes the development of colitis- associated colorectal tumors. Gastroenterology, 2007,133 (6) :1869-1881. 被引量:1
  • 6Fujino H, Chen XB, Regan JW, et al. Indomethacin decreases EP2 prostanoid receptor expression in colon cancer cells. Biochem Biophys Res Commun, 2007,359 (3) : 568-573. 被引量:1
  • 7中华医学会消化病学分会炎症性肠病协作组,欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见(2007年,济南)[J].中华消化杂志,2007,27(8):545-550. 被引量:1024
  • 8Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5- aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med, 1987,317(26) : 1625-1629. 被引量:1
  • 9Truelove SC, Richards WC. Biopsy studies in ulcerative colitis. Br Med J,1956,1(4979) :1315-1318. 被引量:1
  • 10Koga H, Sakisaka S, Ohishi M, et al. Expression of cyclooxygenase-2 in human hepatocellular carcinoma : relevance to tumor dedifferentiation. Hepotology, 1999,29 (3) :688-696. 被引量:1

二级参考文献25

  • 1潘国宗 刘彤华 见:潘国宗 曹世植9. 主编.溃疡性结肠炎[A].见:潘国宗,曹世植9.,主编.现代胃肠病学.第Ⅰ版[C].北京:科学出版社,1994.1246-1247. 被引量:5
  • 2潘国宗 刘彤华.Crohn病[A].见:潘国宗 曹世植 主编.现代胃肠病学[C].北京:科学出版社,1994.1154. 被引量:3
  • 3樋渡信夫 渡边浩光 前川浩树 等.溃疡性结肠炎的诊断标准与诊断进展[J].炎症性肠疾患胃与肠,1997,32(3):271-278. 被引量:3
  • 4欧阳钦.炎症性肠病的诊治进展.见:孟宪镛主编.实用消化病诊疗学.第2版.上海:世界图书出版社,2006.362-84. 被引量:4
  • 5Ouyang Q, Tandon R, Goh KL, et al. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol,2005: 21:408-413. 被引量:1
  • 6Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, con sensus, and implications. Gut, 2006, 55:749-753. 被引量:1
  • 7Zheng JJ. Clinical aspects of ulcerative colitis in China's Mainland. Chin J Dig Dis, 2006, 7:71-75. 被引量:1
  • 8Hanauer SB, Sandborn W, Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol, 2001, 96: 635- 643. 被引量:1
  • 9Stange EF, Travis SP, Vermeire S, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut, 2006, 55 Suppl 1:i1- i15. 被引量:1
  • 10Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut, 2004, 53 Suppl 5: Ⅴ1-Ⅴ16. 被引量:1

共引文献1039

同被引文献71

引证文献6

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部